Market Price

249.78 

-1.34 -0.5%

as of Oct 26 '20

52 Week Range:

127.12 258.62


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 26.08
30.03
16.83
14.55
11.59
11.42
11.70
13.26
15.08
13.89
18.66
growth rate 15.2% -44.0% -13.6% -20.3% -1.5% 2.5% 13.3% 13.7% -7.9% 34.3%
Earnings BIT 222.39
185.58
-478.80
-106.50
-149.10
29.20
68.10
61.77
111.16
155.15
178.94
growth rate -16.6% -100.0% 0.0% 0.0% 100.0% 133.2% -9.3% 80.0% 39.6% 15.3%
Avg.PE 9.93
8.47
-1.80
-4.50
-2.72
70.28
71.22
41.40
47.35
49.38
39.80
growth rate -14.7% -100.0% 0.0% 0.0% 100.0% 1.3% -41.9% 14.4% 4.3% -19.4%
ROA 12.11
9.11
-35.44
-10.52
-13.20
1.83
-0.45
5.25
3.92
15.59
12.81
growth rate -24.8% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% -25.3% 297.7% -17.8%
ROE 20.95
13.96
-54.77
-17.21
-23.33
3.32
-0.75
8.57
6.21
23.94
22.61
growth rate -33.4% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% -27.5% 285.5% -5.6%
ROIC 15.53
11.73
-43.59
-12.07
-19.13
3.83
0.66
7.59
5.73
22.79
18.91
growth rate -24.5% -100.0% 0.0% 0.0% 100.0% -82.8% 1,050.0% -24.5% 297.7% -17.0%
Cur. Ratio 0.95
1.36
1.05
1.00
0.66
0.84
1.00
1.19
1.45
1.01
1.07
growth rate 43.2% -22.8% -4.8% -34.0% 27.3% 19.1% 19.0% 21.9% -30.3% 5.9%
Quick Ratio 0.81
1.21
0.88
0.91
0.44
0.77
0.92
1.14
1.40
0.96
0.84
growth rate 49.4% -27.3% 3.4% -51.7% 75.0% 19.5% 23.9% 22.8% -31.4% -12.5%
Leverage 1.59
1.48
1.65
1.62
1.95
1.69
1.67
1.59
1.58
1.49
1.97
growth rate -6.9% 11.5% -1.8% 20.4% -13.3% -1.2% -4.8% -0.6% -5.7% 32.2%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 150.30
141.50
148.10
169.20
111.10
99.30
127.31
169.06
206.60
192.47
241.60
growth rate -5.9% 4.7% 14.3% -34.3% -10.6% 28.2% 32.8% 22.2% -6.8% 25.5%
Acct.Payable 29.20
20.10
16.10
25.68
30.36
25.38
28.53
31.26
growth rate -31.2% -19.9% 59.5% 18.2% -16.4% 12.4% 9.6%
Cur.Assets 218.00
293.90
232.00
205.80
205.30
135.60
175.26
214.91
311.16
224.12
350.55
growth rate 34.8% -21.1% -11.3% -0.2% -34.0% 29.3% 22.6% 44.8% -28.0% 56.4%
Total Assets 1,172.40
1,299.80
858.30
730.60
726.40
669.70
681.72
734.03
813.48
717.12
1,262.75
growth rate 10.9% -34.0% -14.9% -0.6% -7.8% 1.8% 7.7% 10.8% -11.9% 76.1%
Cash 34.50
120.30
48.00
14.50
17.30
8.00
27.50
30.20
86.36
20.23
30.29
growth rate 248.7% -60.1% -69.8% 19.3% -53.8% 243.8% 9.8% 186.0% -76.6% 49.8%
Inventory 0.00 0.00 0.00 0.00
growth rate
Cur.Liabilities 229.30
216.30
221.70
204.80
312.40
162.30
175.19
181.35
215.06
222.48
326.94
growth rate -5.7% 2.5% -7.6% 52.5% -48.1% 7.9% 3.5% 18.6% 3.5% 47.0%
Liabilities 437.20
422.00
339.40
278.30
354.20
272.60
271.28
272.89
297.06
234.49
621.23
growth rate -3.5% -19.6% -18.0% 27.3% -23.0% -0.5% 0.6% 8.9% -21.1% 164.9%
LT Debt 170.90
144.70
111.60
0.00
0.00
0.00
91.63
87.81
78.20
5.78
230.56
growth rate -15.3% -22.9% -100.0% -4.2% -10.9% -92.6% 3,892.3%
Equity 735.20
877.90
518.90
452.30
372.20
397.20
409.57
460.20
515.32
481.58
640.45
growth rate 19.4% -40.9% -12.8% -17.7% 6.7% 3.1% 12.4% 12.0% -6.6% 33.0%
Common Shares 28.00
28.00
29.00
30.00
31.00
33.00
33.00
34.00
34.00
34.00
33.00
growth rate 0.0% 3.6% 3.5% 3.3% 6.5% 0.0% 3.0% 0.0% 0.0% -2.9%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 36.30
63.90
44.40
47.60
39.90
21.43
15.72
10.71
6.56
7.89
growth rate 76.0% -30.5% 7.2% -16.2% -26.7% -26.7% -31.9% -38.8% 20.3%
Cash Dividends 0.00
0.30
0.70
0.30
0.20
0.00
0.40
0.00
growth rate 133.3% -57.1% -33.3% -100.0% -100.0%
Cash From OA 247.70
206.30
141.20
69.50
102.30
107.79
62.26
105.73
223.48
202.00
growth rate -16.7% -31.6% -50.8% 47.2% 2.7% -42.2% 69.8% 111.4% -9.6%
FCF per Share 7.42
4.91
2.55
0.71
2.08
-2.60
2.19
1.10
2.66
5.42
5.58
growth rate -33.8% -48.1% -72.2% 193.0% -100.0% 100.0% -49.8% 141.8% 103.8% 3.0%
Sale Purchase of Stock 0.00
0.00
0.00
-4.60
-12.30
growth rate 0.0%
FCF 206.00
140.00
97.00
21.00
61.00
-78.00
86.00
47.00
95.00
217.00
194.00
growth rate -32.0% -30.7% -78.4% 190.5% -100.0% 100.0% -45.4% 102.1% 128.4% -10.6%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 1,513.50
1,601.10
1,468.30
1,487.90
1,249.30
1,204.60
1,266.49
1,419.26
1,511.27
1,662.58
1,955.63
growth rate 5.8% -8.3% 1.3% -16.0% -3.6% 5.1% 12.1% 6.5% 10.0% 17.6%
Op.Income 230.70
211.30
-470.00
-97.30
-97.80
13.10
68.10
61.77
111.16
155.15
178.94
growth rate -8.4% -100.0% 0.0% 0.0% 100.0% 419.9% -9.3% 80.0% 39.6% 15.3%
IBT 222.40
203.20
-477.90
-118.70
-153.50
21.00
-0.31
61.57
80.80
158.99
170.41
growth rate -8.6% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% 31.2% 96.8% 7.2%
Net Income 135.80
112.60
-382.50
-83.60
-96.20
12.80
-3.02
37.26
30.30
119.35
126.83
growth rate -17.1% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% -18.7% 293.9% 6.3%
EPS 4.89
3.95
-13.33
-2.79
-3.08
0.39
-0.09
1.10
0.88
3.55
3.84
growth rate -19.2% -100.0% 0.0% 0.0% 100.0% -100.0% 100.0% -20.0% 303.4% 8.2%
Gross Profit 789.00
807.10
687.70
648.30
531.30
513.50
540.57
584.88
607.90
669.72
805.30
growth rate 2.3% -14.8% -5.7% -18.1% -3.4% 5.3% 8.2% 3.9% 10.2% 20.2%

Quarterly Statements

Item Name Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Earnings BIT 44.75
46.84
43.02
44.87
growth rate 4.7% -8.2% 4.3%
Balance Sheet Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Acct.Receivable 239.67
254.70
241.60
268.55
249.03
growth rate 6.3% -5.2% 11.2% -7.3%
Acct.Payable 35.69
35.90
31.26
31.15
33.38
growth rate 0.6% -12.9% -0.4% 7.2%
Cur.Assets 275.79
299.52
350.55
468.13
449.54
growth rate 8.6% 17.0% 33.5% -4.0%
Total Assets 1,205.86
1,212.38
1,262.75
1,440.08
1,645.49
growth rate 0.5% 4.2% 14.0% 14.3%
Cash 13.90
20.76
30.29
174.76
177.28
growth rate 49.3% 46.0% 476.9% 1.4%
Cur.Liabilities 313.01
314.65
326.94
316.11
442.05
growth rate 0.5% 3.9% -3.3% 39.8%
Liabilities 642.92
608.92
621.23
759.94
923.23
growth rate -5.3% 2.0% 22.3% 21.5%
LT Debt 264.67
229.64
230.56
376.84
growth rate -13.2% 0.4% 63.5%
Equity 561.78
602.56
640.45
679.20
720.85
growth rate 7.3% 6.3% 6.1% 6.1%
Common Shares 0.04
0.04
0.04
0.04
0.04
growth rate 2.8% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Capital Expenditures 1.50
3.64
1.55
1.43
growth rate 143.8% -57.4% -7.5%
Cash Dividends
growth rate
Cash From OA 59.27
47.46
75.22
6.04
growth rate -19.9% 58.5% -92.0%
Sale Purchase of Stock
growth rate
FCF 57.77
43.81
73.67
4.60
growth rate -24.2% 68.2% -93.8%
Income Statement Jun '19 Sep '19 Dec '19 Mar '20 Jun '20
Sales 492.98
494.63
500.68
491.69
growth rate 0.3% 1.2% -1.8%
Op.Income 44.75
46.84
43.02
44.87
growth rate 4.7% -8.2% 4.3%
IBT 44.35
44.24
39.37
41.39
45.18
growth rate -0.2% -11.0% 5.1% 9.2%
Net Income 33.74
34.13
27.66
31.80
34.67
growth rate 1.2% -19.0% 15.0% 9.0%
EPS
growth rate
Gross Profit 202.23
205.92
205.08
206.95
growth rate 1.8% -0.4% 0.9%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

C (60.29)

YOY Growth Grade:

F (16.08)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 60.51 64.69 38.49
EPS / Growth 36.3% 3.86 14.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 9.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.0% 11.8% 11.8%
Future PE 18.08 40.89 40.89
Future EPS 9.17 11.82 11.82
Value Price
MOS %
41.00
-83.6%
119.49
-52.2%
119.49
-52.2%
MOS Price 20.50 59.75 59.75
IRT 21.37 18.40 18.40

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.